How Blue Bird’s Micro Bird Deal and Higher Guidance Could Reshape BLBD’s Risk Reward Profile

Blue Bird Corporation

Blue Bird Corporation

BLBD

0.00

  • In recent days, Blue Bird’s acquisition of the remaining stake in its Micro Bird joint venture, a growing order backlog, and raised long-term guidance have reinforced confidence in its future operational performance and profitability.
  • An interesting angle is that this improving business outlook is unfolding alongside mixed third‑party assessments, including a sell rating from one research firm and high institutional ownership with shifting positions among major investors.
  • We’ll now examine how Blue Bird’s raised long-term guidance and Micro Bird acquisition may influence its existing investment narrative and risk profile.

Find 45 companies with promising cash flow potential yet trading below their fair value.

Blue Bird Investment Narrative Recap

To own Blue Bird, you need to believe its core school bus business and growing alternative fuel footprint can support steady orders and healthy margins. Right now, the key near term catalyst is how effectively it converts its backlog into profitable deliveries, while the biggest risk remains policy or funding shifts that could slow demand for cleaner buses. The Micro Bird acquisition and raised long term guidance support the operating story, but do not materially change those fundamental drivers.

The Micro Bird deal is especially relevant here because it pulls a previously shared, profitable small bus platform fully in house, giving Blue Bird more control over product, pricing, and mix. That ties directly into the backlog and guidance story, since tighter control over the Micro Bird line could help support margins and broaden the customer base if funding stays supportive, adding another lever alongside its existing alternative fuel and EV offerings.

Yet even with this progress, investors should be aware that Blue Bird’s above average volatility and reliance on government funding...

Blue Bird's narrative projects $1.7 billion revenue and $167.2 million earnings by 2029.

Uncover how Blue Bird's forecasts yield a $69.29 fair value, a 6% downside to its current price.

Exploring Other Perspectives

BLBD 1-Year Stock Price Chart
BLBD 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming revenue of about US$1.6 billion and earnings near US$159.0 million by 2028, which is a much brighter path than consensus. When you set those expectations against the latest backlog trends and the Micro Bird acquisition, you can see how far opinions can stretch and why it is worth exploring several viewpoints before deciding what you think is realistic.

Explore 4 other fair value estimates on Blue Bird - why the stock might be worth as much as 39% more than the current price!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Blue Bird research is our analysis highlighting 4 key rewards that could impact your investment decision.
  • Our free Blue Bird research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Blue Bird's overall financial health at a glance.

Ready To Venture Into Other Investment Styles?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

  • The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
  • We've uncovered the 8 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
  • AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.